First-in-human phase 1 study of the arginase inhibitor INCB001158 alone or combined with pembrolizumab in patients with advanced or metastatic solid tumours
Aung Naing, Kyriakos P. Papadopoulos, Michael J. Pishvaian, Osama Rahma, Glenn J. Hanna, Elena Garralda, Omar Saavedra, Sven Gogov, Howard Kallender, Lu Lu Cheng, Michael Smith, Xuejun Chen, Emil Kuriakose, Todd Bauer
Dive into the research topics of 'First-in-human phase 1 study of the arginase inhibitor INCB001158 alone or combined with pembrolizumab in patients with advanced or metastatic solid tumours'. Together they form a unique fingerprint.